Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-16

Clinical Trial Update: Aspirin for Treatment of Multiple Sclerosis-Related Fatigue [Phase 3]

View source ↗

Summary

A Phase 3 trial of aspirin for treatment of multiple sclerosis-related fatigue was terminated, and the results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Sclerosis, Fatigue | Phase 3 | Status: TERMINATED | Results posted: 2014-05-16